Reversal of liver cirrhosis: current evidence and expectations.
about
Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells.Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma
P2860
Reversal of liver cirrhosis: current evidence and expectations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Reversal of liver cirrhosis: current evidence and expectations.
@en
type
label
Reversal of liver cirrhosis: current evidence and expectations.
@en
prefLabel
Reversal of liver cirrhosis: current evidence and expectations.
@en
P2860
P356
P1476
Reversal of liver cirrhosis: current evidence and expectations.
@en
P2093
Hyung Joon Yim
Young Kul Jung
P2860
P304
P356
10.3904/KJIM.2016.268
P5008
P577
2017-02-08T00:00:00Z
2017-03-01T00:00:00Z